Safety of REL-1017 for Major Depressive Disorder
Public ClinicalTrials.gov record NCT04855760. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Open-Label Study to Assess the Long-Term Safety of REL-1017 as a Treatment of Major Depressive Disorder
Study identification
- NCT ID
- NCT04855760
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Relmada Therapeutics, Inc.
- Industry
- Enrollment
- 627 participants
Conditions and interventions
Conditions
Interventions
- REL-1017 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2021
- Primary completion
- Jul 26, 2023
- Completion
- Jul 26, 2023
- Last update posted
- Feb 10, 2025
2021 – 2023
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Relmada Site | Miami | Florida | 33015 | — |
| Relmada Site | Miami | Florida | 33175 | — |
| Relmada Site | Orlando | Florida | 32801 | — |
| Relmada Site | Palm Bay | Florida | 32905 | — |
| Relmada Site | Chicago | Illinois | 60634 | — |
| Relmada Site | Chicago | Illinois | 60640 | — |
| Relmada Site | Boston | Massachusetts | 02116 | — |
| Relmada Site | Watertown | Massachusetts | 02472 | — |
| Relmada Site | Staten Island | New York | 10312 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04855760, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04855760 live on ClinicalTrials.gov.